Evidence map›Paper›PMID 25158274›Full record

Observational studyThe Journal of urology2015

5-year longitudinal followup after retropubic and transobturator mid urethral slings.

Kimberly Kenton, Anne M Stoddard, Halina Zyczynski, Michael Albo, Leslie Rickey, Peggy Norton, Clifford Wai, Stephen R Kraus, Larry T Sirls, John W Kusek and 3 more

4 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in The Journal of urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 38 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04843995 completednot on this map

The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion

TypeobservationalSponsorEndeavor HealthRan2012 to 2021Enrolled190ConditionsStress Urinary IncontinenceArmsMid-urethral sling
NCT04881721 unknown statusnot on this mapstarted 2021, after this paper: background citation

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

TypeobservationalSponsorEndeavor HealthRan2021 to 2023Enrolled15ConditionsStress Urinary IncontinenceArmsUrethropexy
NCT05682989 recruitingnot on this mapstarted 2022, after this paper: background citation

Evaluation of Efficacy and Safety of Urogynecology Synthetic Mesh Surgery in Women With Pelvic Organ Prolapse

TypeobservationalSponsorMackay Medical CollegeRan2022 to 2027Enrolled150ConditionsPelvic Organ Prolapse, Stage III and IV High Grade Pelvic Organ ProlapseArmsUrodynamic investigations before and after a mesh surgery protocol., Urodynamic investigations before and after a robotic-assisted sacrocolpopexy protocol., Urodynamic investigations before and after a hysterectomy with trans-vaginal mesh repair
NCT05842005 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Mesh-Reduced Sling For Treating Stress Urinary Incontinence, Efficacy and Durability Trial

TypeinterventionalSponsorEndeavor HealthRan2023 to 2024Enrolled15ConditionsStress Urinary IncontinenceArmsMesh-reduced Sling
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Mid-urethral sling operations for stress urinary incontinence in women.The Cochrane database of systematic reviews · 2017
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Efficacy of the Sub-Urethral Transobturator KIM SystemJournal of clinical medicine · 2024
    Article
  14. Article
  15. 2024 Canadian Urological Association guideline: Female stress urinary incontinence.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kimberly KentonNorthwestern University, Chicago, Illinois. Electronic address: kimberly.kenton@northwestern.edu.
Anne M StoddardNew England Research Institutes, Watertown, Massachusetts.
Halina ZyczynskiUniversity of Pittsburgh, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
Michael AlboUniversity of California San Diego, San Diego, California.
Leslie RickeyYale University, New Haven, Connecticut.
Peggy NortonUniversity of Utah, Salt Lake City, Utah.
Clifford WaiUniversity of Texas Southwestern, Dallas, Texas.
Stephen R KrausUniversity of Texas Health Sciences Center at San Antonio, San Antonio, Texas.
Larry T SirlsWilliam Beaumont Hospital, Royal Oak, Michigan.
John W KusekNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Heather J LitmanBoston Children's Hospital, Boston, Massachusetts.
Robert P ChangNew England Research Institutes, Watertown, Massachusetts.
Holly E RichterUniversity of Alabama at Birmingham, Birmingham, Alabama for the Urinary Incontinence Treatment Network.

Funding

Urinary Incontinence Treatment Network: DCCU01DK058229 · NIDDK · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI TENNSTEDT, SHARON L · 2000 to 2012
$16.1M
UAB Continence Treatment Center U01DK060380 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RICHTER, HOLLY E · 2001 to 2009
$3.9M
Urinary Incontinence Treatment NetworkU01DK058225 · NIDDK · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI ZYCZYNSKI, HALINA M · 2000 to 2009
$3.8M
UCSD INCONTINENCE TREATMENT CENTERU01DK060401 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALBO, MICHAEL · 2001 to 2010
$3.6M
Continuation of the Urinary Incontinence Treatment Network (UITN)U01DK060379 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA · 2001 to 2009
$3.6M
UTAH URINARY INCONTINENCE TREATMENT NETWORK (UUITN)U01DK060393 · NIDDK · UNIVERSITY OF UTAH · PI NORTON, PEGGY A · 2001 to 2009
$3.4M
Urinary Incontinence Treatment NetworkU01DK058231 · NIDDK · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI SIRLS, LARRY T · 2000 to 2009
$3.3M
Urinary Incontinence Treatment Network (UITN)U01DK060397 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI CHAI, TOBY C · 2001 to 2010
$2.7M
Urinary Incontinence Treatment NetworkU01DK060395 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ZIMMERN, PHILIPPE E · 2001 to 2009
$2.4M
The Urinary Incontinence Treatment NetworkU01DK058234 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KRAUS, STEPHEN R · 2000 to 2009
$2.3M
NIDDK NIH HHS U01 DK058225NIDDK NIH HHS U01 DK058229NIDDK NIH HHS U01 DK058231NIDDK NIH HHS U01 DK058234NIDDK NIH HHS U01 DK060379NIDDK NIH HHS U01 DK060380NIDDK NIH HHS U01 DK060393NIDDK NIH HHS U01 DK060395NIDDK NIH HHS U01 DK060397NIDDK NIH HHS U01 DK060401NIDDK NIH HHS U01 DK 58225NIDDK NIH HHS U01 DK58229NIDDK NIH HHS U01 DK58231NIDDK NIH HHS U01 DK58234NIDDK NIH HHS U01 DK60379NIDDK NIH HHS U01 DK60380NIDDK NIH HHS U01 DK60393NIDDK NIH HHS U01 DK60395NIDDK NIH HHS U01 DK60397NIDDK NIH HHS U01 DK60401PHS HHS NIH NIDDK 1U10 DK60379-01
6 · The paper itself

Abstract

purposeFew studies have characterized longer-term outcomes after retropubic and transobturator mid urethral slings. MATERIALS AND

methodsWomen completing 2-year participation in a randomized equivalence trial who had not undergone surgical re-treatment for stress urinary incontinence were invited to participate in a 5-year observational cohort. The primary outcome, treatment success, was defined as no re-treatment or self-reported stress incontinence symptoms. Secondary outcomes included urinary symptoms and quality of life, satisfaction, sexual function and adverse events.

resultsOf 597 women 404 (68%) from the original trial enrolled in the study. Five years after surgical treatment success was 7.9% greater in women assigned to the retropubic sling compared to the transobturator sling (51.3% vs 43.4%, 95% CI -1.4, 17.2), not meeting prespecified criteria for equivalence. Satisfaction decreased during 5 years but remained high and similar between arms (retropubic sling 79% vs transobturator sling 85%, p=0.15). Urinary symptoms and quality of life worsened with time (p <0.001), and women with a retropubic sling reported greater urinary urgency (p=0.001), more negative impact on quality of life (p=0.02) and worse sexual function (p=0.001). There was no difference in the proportion of women experiencing at least 1 adverse event (p=0.17). Seven new mesh erosions were noted (retropubic sling 3, transobturator sling 4).

conclusionsTreatment success decreased during 5 years for retropubic and transobturator slings, and did not meet the prespecified criteria for equivalence with retropubic demonstrating a slight benefit. However, satisfaction remained high in both arms. Women undergoing a transobturator sling procedure reported more sustained improvement in urinary symptoms and sexual function. New mesh erosions occurred in both arms over time, although at a similarly low rate.

Indexed as

Suburethral SlingsUrinary Incontinence, StressFemaleFollow-Up StudiesHumansLongitudinal StudiesMiddle AgedRandomized Controlled Trials as TopicTime Factorsstresssuburethral slingsurinary incontinence

Identifiers

PMID25158274
PMCPMC4272663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.